The prognosis of patients with peritoneal mesothelioma and mesothelioma
patients is poor is no exception. Most peritoneal care regimen that made
against patients, including palliative methods, such as radiation therapy and
chemotherapy mesothelioma. However, if the patient sufferer of this disease is
diagnosed early, patients such as those diagnosed with mesothelioma in stage
one, may be eligible for surgical resection done disease, which potentially
could add years to the early prognosis.
Operation is possible for patients who are diagnosed with the disease the
previous stage. Some options include surgery and palliative procedures a
peritonectomy. Some doctors, like Dr. David Sugarbaker, the international
Mesothelioma Program at Brigham and women's Hospital in Boston, MA, has a very
good experience and have experience in performing surgical treatment of
malignant mesothelioma. In many cases, surgical treatment for mesothelioma
patients will be combined with radiation therapy or chemotherapy regimen.
Chemotherapy is one of the most common treatments are carried out for the
disease mesothelioma. Currently, there are still only one chemotherapy regimen
(Alimta ® (pemetrexed) in relation to Cisplatin) which has been approved by the
Food and Drug Administration as a therapy that has been prescribed for the
treatment of malignant pleural mesothelioma. Nevertheless, there are still
dozens of other clinical trials that are being conducted to treat patients
suffering from malignant peritoneal mesothelioma.